Moderna Inc. Stock Advances 9.9%, Outperforms Peers
Dow Jones2026/09/01 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. rallied 9.9% to $154.27 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.
This was the stock's second consecutive day of gains.
Moderna Inc. closed 12.7% short of its 52-week high of $176.66, which the company achieved on August 19th.
The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Gilead Sciences Inc. rose 2.45% to $149.92.
Trading volume totaled 25.3 million, compared to the 50-day average of 16.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 01, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
EIA expects Brent crude spot prices to remain at $100 per barrel for the rest of the year and raises the average price forecasts for this year and next.
The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.
Moody’s and Chainlink Complete Cross-Chain Credit Ratings Distribution Pilot
Crypto prices
More
